Towards Healthcare
Bilirubin Blood Test Market Expands at 6.67% CAGR by 2034

Bilirubin Blood Test Market AI Integration, Neonatal Focus and Roche’s India Expansion Fuels Growth

Projections indicate that, the global bilirubin blood test market will increase from USD 1.29 billion in 2024 to USD 2.46 billion by 2034, experiencing a CAGR of 6.67% over the next 10 years.The market is expanding due to the rising prevalence of liver diseases and neonatal jaundice, necessitating early and accurate diagnosis. Additionally, advancements in non-invasive testing technology and increased public awareness about liver health are driving demand for these diagnostic tests.

Content

  • Insight Code: 5848
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The bilirubin blood test market is projected to reach USD 2.46 billion by 2034, growing at a CAGR of 6.67% from 2024 to 2034.

The strongyloidiasis treatment market includes 5 segments by test type, by application, by technology, by end user, and by region.

Some key players include Thermo Fisher Scientific Inc., Radiometer Medical, Philips Healthcare, Dragerwerk AG & Co. KGaA, Nova Biomedical, Bayer AG, and Arkray Inc.

Key trends include the growth due to the rising prevalence of liver diseases and neonatal jaundice, necessitating early and accurate diagnosis.

It helps evaluate liver function, detect jaundice, and diagnose conditions like liver disease, bile duct obstruction, or hemolytic anemia.

A blood sample is drawn from a vein, usually in your arm. The test is quick and typically takes only a few minutes.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions